Table V.
Factors associated with QLACS Score in Survivors (n=59)
Overall Total Score | Total Generic Score | |||
---|---|---|---|---|
Coeff (95% CI) | P value | Coeff (95% CI) | P value | |
Age at visit | 0.46 (−0.73–1.65) | 0.44 | 0.94 (−0.08–2.0) | 0.07 |
Years since diagnosis | −0.23 (−1.1–0.62) | 0.59 | 0.11 (−0.65–0.87) | 0.78 |
Cancer type | 11.4 (3.35–19.4) | 0.006 | 3.4 (−4.1–10.9) | 0.37 |
Alkylator exposure | 2.7 (−0.9–6.2) | 0.14 | −10.3 (−31.6–11.1) | 0.34 |
Radiation exposure | −9.0 (−46.0–28.0) | 0.63 | −29.7 (−61.9–2.4) | 0.07 |
Regular cycles | 14.0 (−0.23–28.3) | 0.054 | 15.6 (3.4–27.8) | 0.013 |
BMI (kg/m2) | 0.83 (−0.77–2.4) | 0.30 | 0.44 (−0.95–1.8) | 0.53 |
FSH (mIU/mL) | 1.6 (−6.1–9.4) | 0.67 | 2.1 (−4.6–8.9) | 0.53 |
LH (mIU/mL) | −2.4 (−12.5–7.8) | 0.64 | −0.69 (−8.9—7.8) | 0.87 |
E2 (pg/mL) | −5.9 (−15.8–3.9) | 0.23 | −3.8 (−12.6–5.0) | 0.39 |
AMH (ng/mL) | −3.2 (−7.5–1.1) | 0.14 | −2.0 (−5.8–1.8) | 0.29 |
Inhibin B (pg/mL) | −4.8 (−12.7–3.1) | 0.23 | −5.2 (−11.9–1.6) | 0.13 |
Total AFC | −0.23 (−0.77–0.31) | 0.40 | −0.08 (0.60–0.40) | 0.72 |